鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/04/27 | 2,854 | 2,900 | 2,854 | 2,886 | +8 | +0.3% | 20,200 |
2017/04/26 | 2,851 | 2,887 | 2,850 | 2,878 | +14 | +0.5% | 23,000 |
2017/04/25 | 2,877 | 2,877 | 2,841 | 2,864 | -2 | -0.1% | 23,900 |
2017/04/24 | 2,850 | 2,878 | 2,837 | 2,866 | +48 | +1.7% | 20,100 |
2017/04/21 | 2,782 | 2,820 | 2,774 | 2,818 | +36 | +1.3% | 13,300 |
2017/04/20 | 2,787 | 2,794 | 2,762 | 2,782 | -17 | -0.6% | 19,700 |
2017/04/19 | 2,801 | 2,839 | 2,799 | 2,799 | -34 | -1.2% | 15,800 |
2017/04/18 | 2,840 | 2,852 | 2,813 | 2,833 | +4 | +0.1% | 18,700 |
2017/04/17 | 2,780 | 2,836 | 2,780 | 2,829 | +28 | +1% | 9,300 |
2017/04/14 | 2,814 | 2,834 | 2,792 | 2,801 | -57 | -2% | 25,800 |
2017/04/13 | 2,805 | 2,858 | 2,805 | 2,858 | +20 | +0.7% | 30,800 |
2017/04/12 | 2,810 | 2,841 | 2,799 | 2,838 | -6 | -0.2% | 23,900 |
2017/04/11 | 2,851 | 2,880 | 2,834 | 2,844 | +1 | ±0% | 32,200 |
2017/04/10 | 2,880 | 2,889 | 2,837 | 2,843 | -30 | -1% | 38,600 |
2017/04/07 | 2,842 | 2,899 | 2,835 | 2,873 | +14 | +0.5% | 32,700 |
2017/04/06 | 2,880 | 2,889 | 2,852 | 2,859 | -47 | -1.6% | 39,500 |
2017/04/05 | 2,881 | 2,923 | 2,881 | 2,906 | +18 | +0.6% | 28,600 |
2017/04/04 | 2,895 | 2,914 | 2,866 | 2,888 | -23 | -0.8% | 57,500 |
2017/04/03 | 2,872 | 2,936 | 2,861 | 2,911 | +39 | +1.4% | 76,000 |
2017/03/31 | 2,923 | 2,943 | 2,872 | 2,872 | -63 | -2.1% | 42,200 |
2017/03/30 | 2,957 | 2,970 | 2,917 | 2,935 | -32 | -1.1% | 33,100 |
2017/03/29 | 2,959 | 2,978 | 2,925 | 2,967 | +31 | +1.1% | 44,300 |
2017/03/28 | 2,886 | 2,936 | 2,872 | 2,936 | +86 | +3% | 32,700 |
2017/03/27 | 2,923 | 2,926 | 2,845 | 2,850 | -111 | -3.7% | 63,900 |
2017/03/24 | 2,955 | 2,964 | 2,918 | 2,961 | +13 | +0.4% | 29,600 |
2017/03/23 | 2,925 | 2,952 | 2,910 | 2,948 | +35 | +1.2% | 34,000 |
2017/03/22 | 2,911 | 2,943 | 2,898 | 2,913 | -43 | -1.5% | 34,000 |
2017/03/21 | 2,945 | 2,964 | 2,938 | 2,956 | -2 | -0.1% | 23,800 |
2017/03/17 | 2,973 | 2,996 | 2,929 | 2,958 | -42 | -1.4% | 44,600 |
2017/03/16 | 2,967 | 3,010 | 2,967 | 3,000 | +10 | +0.3% | 38,400 |
2017/03/15 | 2,972 | 2,995 | 2,965 | 2,990 | +7 | +0.2% | 18,800 |
2017/03/14 | 3,015 | 3,020 | 2,974 | 2,983 | -10 | -0.3% | 38,900 |
2017/03/13 | 3,025 | 3,040 | 2,977 | 2,993 | -12 | -0.4% | 30,800 |
2017/03/10 | 3,000 | 3,050 | 2,976 | 3,005 | +41 | +1.4% | 59,300 |
2017/03/09 | 2,947 | 2,969 | 2,935 | 2,964 | +5 | +0.2% | 24,300 |
2017/03/08 | 2,969 | 2,978 | 2,936 | 2,959 | -1 | ±0% | 33,000 |
2017/03/07 | 2,941 | 2,962 | 2,933 | 2,960 | +35 | +1.2% | 22,300 |
2017/03/06 | 3,000 | 3,000 | 2,920 | 2,925 | -75 | -2.5% | 28,900 |
2017/03/03 | 2,997 | 3,030 | 2,981 | 3,000 | -10 | -0.3% | 33,200 |
2017/03/02 | 2,998 | 3,035 | 2,989 | 3,010 | +34 | +1.1% | 53,900 |
2017/03/01 | 2,947 | 2,981 | 2,919 | 2,976 | +34 | +1.2% | 46,000 |
2017/02/28 | 2,938 | 3,000 | 2,938 | 2,942 | +42 | +1.4% | 58,000 |
2017/02/27 | 2,911 | 2,923 | 2,881 | 2,900 | -32 | -1.1% | 37,600 |
2017/02/24 | 2,978 | 2,986 | 2,924 | 2,932 | -48 | -1.6% | 50,700 |
2017/02/23 | 2,947 | 2,980 | 2,935 | 2,980 | +34 | +1.2% | 44,900 |
2017/02/22 | 2,911 | 2,949 | 2,882 | 2,946 | +31 | +1.1% | 40,700 |
2017/02/21 | 2,909 | 2,926 | 2,895 | 2,915 | +6 | +0.2% | 43,300 |
2017/02/20 | 2,888 | 2,919 | 2,873 | 2,909 | -7 | -0.2% | 44,500 |
2017/02/17 | 2,871 | 2,920 | 2,847 | 2,916 | +45 | +1.6% | 47,200 |
2017/02/16 | 2,865 | 2,890 | 2,858 | 2,871 | -11 | -0.4% | 24,100 |
1851~
1900
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 478,000円 | +12.0% | +28.1% | 2.51% | 26.35倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
東和薬品 | 285,000円 | +15.0% | -7.3% | 2.11% | 9.35倍 | 0.88倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 284,600円 | +52.1% | +23.3% | 0.00% | 20.21倍 | 3.87倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 334,000円 | +3.0% | +27.5% | 2.40% | 21.15倍 | 0.92倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 226,400円 | +13.6% | +29.2% | 2.03% | 11.74倍 | 1.13倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム